SPONSOR
Seoul National University Hospital
Total Trials
17
Recruiting
17
Phases
Phase 1, Phase 2
Conditions studied: Brain Tumor, PrimaryMeningiomaSchwannomaPituitary AdenomaGliomas BenignAtrial FibrillationAcute Kidney InjuryPediatric Cardiac SurgeryBreast Cancer InvasiveB-cell Acute Lymphoblastic Leukemia
Seoul National University Hospital is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including Brain Tumor, Primary, Meningioma, Schwannoma, Pituitary Adenoma.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Seoul National University Hospital
How many clinical trials has Seoul National University Hospital sponsored?
ClinicalMetric currently tracks 17 clinical trials sponsored by Seoul National University Hospital, of which 17 are actively recruiting participants. These trials cover conditions including Brain Tumor, Primary, Meningioma, Schwannoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Seoul National University Hospital research focus on?
Seoul National University Hospital clinical trials span Brain Tumor, Primary, Meningioma, Schwannoma, Pituitary Adenoma, Gliomas Benign, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Seoul National University Hospital clinical trial?
To participate in a Seoul National University Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Seoul National University Hospital trials with current recruitment status updated daily.
Clinical Trials by Seoul National University Hospital
NCT05254197
Recruiting
SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)
Brain Tumor, Primary
NCT05794386
Recruiting
SCAR Burden of Left Atrium Guided cathEter Ablation sTrategy for Persistent Atrial Fibrillation
Atrial Fibrillation
NCT06710353
Recruiting
The Effect of Preoperative Albumin Administration on Postoperative Acute Kidney Injury in Pediatric Patients With Hypoalbuminemia Undergoing Cardiac Surgery
Acute Kidney Injury
NCT05505357
Recruiting
Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST)
Breast Cancer Invasive
NCT05210907 Phase 1
Recruiting
Clinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic Leukemia
B-cell Acute Lymphoblastic Leukemia
NCT05250557
Recruiting
Prognostic Impact of Lesion-specific Hemodynamic Index in Patients With Coronary Artery Disease
Coronary Artery Disease
NCT07011979
Recruiting
SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD)
NCT05599880 Phase 2
Recruiting
The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia
Relapsed/Refractory Immune Thrombocytopenia
NCT06380049
Recruiting
Predicting Fall Risk in Stroke Patients Using a Machine Learning Model and Multi-Sensor Data
Stroke
NCT03929887
Recruiting
KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
Glomerular Disease
NCT07377695
Recruiting
Remimazolam Consumption: TCI vs. Manual Infusion
Moyamoya Disease
NCT07636044
Recruiting
Reduced Vaccine Response to HZ/su in SLE
Vaccine Reaction
NCT07363278
Recruiting
A Prospective Observational Study Evaluating the Incidence of Silent Cerebral Lesions and Procedural Safety Following Atrial Fibrillation Ablation Using the VARIPULSE™ Pulsed Field Ablation System
Atrial Fibrillation (AF)
NCT07509359
Recruiting
Comparing Basilic and Cephalic Vein Approaches for Midline Catheter Placement in Children
Vascular Access Device Complications
NCT06205355
Recruiting
Analgesia Nociception Index in Orthognathic Surgery
Postoperative Pain
NCT06920251 Phase 2
Recruiting
Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy
Relapsed Refractory Multiple Myeloma (RRMM)
NCT06363357
Recruiting
The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Neuromuscular Disorder
Muscular Dystrophy, Duchenne
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology